• Privacy Policy
  • About Us
  • Contact Us
  • Home
  • Business
  • Computers
  • Gear
  • Real Estate
  • Review
  • Technology
No Result
View All Result
  • Home
  • Business
  • Computers
  • Gear
  • Real Estate
  • Review
  • Technology
No Result
View All Result
Cartographeum
No Result
View All Result

Coronavirus | Pfizer ends COVID-19 vaccine trial with 95% efficacy, to seek emergency-use authorisation

Juliet Woodard by Juliet Woodard
November 18, 2020
Home Business
Share on FacebookShare on Twitter

Moderna Inc on November 16 released preliminary data for its vaccine, showing similar effectiveness.

Pfizer Inc said on Wednesday that final results from the late-stage trial of its COVID-19 vaccine show it was 95% effective, adding it had the required two-months of safety data and would apply for emergency U.S. authorization within days.The drugmaker said efficacy of the vaccine developed with German partner BioNTech SE was consistent across age and ethnicity demographics, and that there were no major side effects, a sign that the immunization could be employed broadly around the world.Efficacy in adults over 65 years, who are at particular risk from the virus, was over 94%.The final analysis comes just one week after initial results from the trial showed the vaccine was more than 90% effective. Moderna Inc on Monday released preliminary data for its vaccine, showing similar effectiveness.The better-than-expected data from the two vaccines, both developed with new technology known as messenger RNA (mRNA), have raised hopes for an end to a resurgent pandemic that has killed more than 1.3 million people globally and wreaked havoc upon economies and daily life.Also read: UNICEF to stockpile half a billion syringes for COVID-19 vaccinationsHowever, while some groups such as healthcare workers will be prioritized in the United States for vaccinations this year, it will be months before large-scale rollouts begin.Pfizer said on Wednesday there had been 170 cases of the disease in its trial of more 43,000 volunteers, of which 162 were observed in the placebo arm and 8 were in the vaccine group.Ten people developed severe COVID-19, one of whom received the vaccine.It also said the vaccine was well-tolerated and that side effects were mostly mild to moderate and cleared up quickly.The only severe adverse event that affected more than 2% of those vaccinated was fatigue, which affected 3.7% of recipients after the second dose. Older adults tended to report fewer and milder solicited adverse events following vaccination.The results come as the virus is running rampant in the United States, Europe and elsewhere, placing an enormous strain on healthcare systems with record numbers of new cases and hospitalizations.The approach of winter in the northern hemisphere in tandem with the holiday season is expected to worsen case numbers as people spend more time indoors and get together for family gatherings.“With hundreds of thousands of people around the globe infected every day, we urgently need to get a safe and effective vaccine to the world,” Pfizer CEO Albert Bourla said in a statement.Also read: Bharat Biotech’s COVID-19 vaccine Covaxin enters phase-3 trialsPfizer and BioNTech also said they plan to submit the data to other regulatory agencies around the world as well as the United States. They also plan to submit data from the study to a peer-reviewed scientific journal.Pfizer reiterated it expects to make as many as 50 million vaccine doses this year, enough to protect 25 million people, and then produce up to 1.3 billion doses in 2021.Of the dozens of drugmakers and research groups racing to develop vaccines against COVID-19, the next data release will likely be from AstraZeneca Plc with the University of Oxford in November or December. Johnson & Johnson says it is on track to deliver data this year.
 

Tags: coronavirus vaccineCoronavirus vaccine pfizerCOVID-19COVId-19 vaccinepfizerPfizer vaccine
Juliet Woodard

Juliet Woodard

Next Post
Google Home App Gets Intuitive Multi-Speaker UI, Routine Triggers, New Preferred Activities Feature

Google Home App Gets Intuitive Multi-Speaker UI, Routine Triggers, New Preferred Activities Feature

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended.

Samsung Exynos 1080 SoC to Launch on November 12, May Not Power Galaxy S21 Series

Samsung Exynos 1080 SoC to Launch on November 12, May Not Power Galaxy S21 Series

November 2, 2020
Alibaba

Alibaba’s Ant Group Files for Blockbuster Hong Kong, Shanghai Dual Listing

August 25, 2020

Trending.

Navigating Online Marketplaces? 12 Tips For Real Estate Newbies

Navigating Online Marketplaces? 12 Tips For Real Estate Newbies

January 13, 2021
Brookfield to buy 18% of RMZ’s assets for $2 billion

Brookfield to buy 18% of RMZ’s assets for $2 billion

October 19, 2020
Rock Legend Gene Simmons Kisses His California Estate And High Taxes Goodbye

Rock Legend Gene Simmons Kisses His California Estate And High Taxes Goodbye

November 1, 2020
Cooperative NAFED floats bids for supply of 15,000 tonnes of imported red onions by Nov 20

Cooperative NAFED floats bids for supply of 15,000 tonnes of imported red onions by Nov 20

October 31, 2020
NPPA caps price of liquid medical oxygen, medical oxygen cylinders

NPPA caps price of liquid medical oxygen, medical oxygen cylinders

September 26, 2020

Cartographeum brings you the latest information about Tech,Real Estate & Business.

Follow Us

Categories

  • Business
  • Computers
  • Gear
  • Real Estate
  • Review
  • Technology
  • Uncategorized

Tags

Amazon Apple Watch 2 Best iPhone 7 deals Bombay stock exchange BSE Business Buying Guides china closing trade coronavirus COVID-19 currency dollar rate economy Finance Ministry foreign exchange forex gold india indian economy Indian stock market Industry iOS 10 lockdown luxury homes market and exchange markets nifty Nirmala Sitharaman NSE oil pandemic Playstation 4 Pro rbi real estate Reserve Bank of India rupee rupee rate Rupee value rupee vs dollar sensex Sillicon Valley stock exchange Stocks USD

Recent News

From Benchwarmer To $13 Billion

From Benchwarmer To $13 Billion

January 23, 2021
Holmby Hills Estate With Scores Of Hollywood Ties Seeks $58 Million

Holmby Hills Estate With Scores Of Hollywood Ties Seeks $58 Million

January 23, 2021
  • Privacy Policy
  • About Us
  • Contact Us

© 2021 JNews - Premium WordPress news & magazine theme by Jegtheme.

No Result
View All Result
  • Home
  • Review
  • Computers
  • Gear

© 2021 JNews - Premium WordPress news & magazine theme by Jegtheme.